ESMO 2016: Press brief on the affordability and access to cancer medicines in Europe
The difficulties in treating squamous cell lung cancer
How can patients undergoing immunotherapy be supported?
Rucaparib and ARIEL3 – positive results from the Phase 3 trial in ovarian cancer patients
Overcoming challenges of imaging in oligometastatic prostate cancer